Cell adhesion molecules in endometriosis: a stage- and compartment-resolved critical review of functional evidence and biomarker validity

Background/Objectives Cell adhesion molecules (CAMs) contribute to attachment, invasion, persistence and inflammatory remodelling in endometriosis, but their interpretation depends on biological stage, tissue compartment, lesion phenotype and assay context. A 2026 review focused on hypoxia-induced regulation of adhesion molecules and related diagnostic and therapeutic implications. Here, we address a complementary question: how direct, reproducible and endometriosis-specific is the evidence for individual adhesion systems, and how far has each signal progressed from mechanism to a clinically validated biomarker? Methods This targeted narrative review considered literature identified through PubMed/MEDLINE, Scopus, Web of Science and Google Scholar, with a targeted update of PubMed-indexed records and publisher databases completed on 13 August 2026. It incorporated targeted full-text studies of integrins, cadherins, CD44, selectins, ICAM-1, VCAM-1, nectins, L1CAM and syndecan-4. Human tissue and fluid studies were prioritised, while relevant in vitro and animal studies were included for functional or perturbational evidence; experiments using non-endometriosis donor tissue were interpreted as mechanistic context. Evidence was organised by biological stage, compartment, phenotype, directness of functional testing and biomarker-development stage. Diagnostic claims were appraised using BEST, STARD and diagnostic-accuracy concepts; no formal GRADE score or systematic-review risk-of-bias grade was assigned. Results The evidence supports a stage- and compartment-resolved model rather than a single adhesion signature. β1-family integrins contribute to binding of menstrual endometrium to extracellular-matrix substrates, whereas blocking α2, α3 or β1 did not reduce initial attachment to an intact mesothelial monolayer under the tested in vitro conditions. E-cadherin is reduced in peritoneal lesions, while selected epithelial CD44 staining is lower relative to secretory eutopic endometrium; N-cadherin, nectins and related junctional proteins show cell-, cycle- and site-dependent patterns. Syndecan-4 has comparatively direct perturbational evidence from an immortalised 12Z cell model, in which knockdown reduced invasion. L1CAM illustrates translational attrition: tissue expression and neurite-outgrowth activity were observed without a corresponding increase in peritoneal-fluid concentrations. Soluble VCAM-1 (sVCAM-1), sICAM-1 and sE-selectin have yielded moderate-to-high same-cohort discrimination or pain associations, but external validation is absent, urinary results are negative and clinically realistic differential diagnoses remain insufficiently represented. Conclusion Among the CAMs and studies evaluated here, no individual molecule or ratio is ready for routine diagnosis. Progress requires stage-specific functional experiments, strict separation of tissue and soluble forms, harmonised preanalytics, prospective multicentre validation and demonstration of incremental value beyond symptoms and expert imaging.

Authors

Institutions

Publication Details

Journal
Frontiers in Molecular Biosciences
Published
2026-11-20
DOI
https://doi.org/10.3389/fmolb.2026.2013778
Primary Topic
Endometriosis Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cell adhesion molecules in endometriosis: a stage- and compartment-resolved critical review of functional evidence and biomarker validity

Ksawery Goławski, Piotr Pierzyński, Cezary Wojtyła, Piotr Laudański
Frontiers in Molecular Biosciences
Endometriosis Research and Treatment
article

Cell adhesion molecules in endometriosis: a stage- and compartment-resolved critical review of functional evidence and biomarker validity

Ksawery Goławski, Piotr Pierzyński, Cezary Wojtyła, Piotr Laudański
article en

Abstract

Background/Objectives Cell adhesion molecules (CAMs) contribute to attachment, invasion, persistence and inflammatory remodelling in endometriosis, but their interpretation depends on biological stage, tissue compartment, lesion phenotype and assay context. A 2026 review focused on hypoxia-induced regulation of adhesion molecules and related diagnostic and therapeutic implications. Here, we address a complementary question: how direct, reproducible and endometriosis-specific is the evidence for individual adhesion systems, and how far has each signal progressed from mechanism to a clinically validated biomarker? Methods This targeted narrative review considered literature identified through PubMed/MEDLINE, Scopus, Web of Science and Google Scholar, with a targeted update of PubMed-indexed records and publisher databases completed on 13 August 2026. It incorporated targeted full-text studies of integrins, cadherins, CD44, selectins, ICAM-1, VCAM-1, nectins, L1CAM and syndecan-4. Human tissue and fluid studies were prioritised, while relevant in vitro and animal studies were included for functional or perturbational evidence; experiments using non-endometriosis donor tissue were interpreted as mechanistic context. Evidence was organised by biological stage, compartment, phenotype, directness of functional testing and biomarker-development stage. Diagnostic claims were appraised using BEST, STARD and diagnostic-accuracy concepts; no formal GRADE score or systematic-review risk-of-bias grade was assigned. Results The evidence supports a stage- and compartment-resolved model rather than a single adhesion signature. β1-family integrins contribute to binding of menstrual endometrium to extracellular-matrix substrates, whereas blocking α2, α3 or β1 did not reduce initial attachment to an intact mesothelial monolayer under the tested in vitro conditions. E-cadherin is reduced in peritoneal lesions, while selected epithelial CD44 staining is lower relative to secretory eutopic endometrium; N-cadherin, nectins and related junctional proteins show cell-, cycle- and site-dependent patterns. Syndecan-4 has comparatively direct perturbational evidence from an immortalised 12Z cell model, in which knockdown reduced invasion. L1CAM illustrates translational attrition: tissue expression and neurite-outgrowth activity were observed without a corresponding increase in peritoneal-fluid concentrations. Soluble VCAM-1 (sVCAM-1), sICAM-1 and sE-selectin have yielded moderate-to-high same-cohort discrimination or pain associations, but external validation is absent, urinary results are negative and clinically realistic differential diagnoses remain insufficiently represented. Conclusion Among the CAMs and studies evaluated here, no individual molecule or ratio is ready for routine diagnosis. Progress requires stage-specific functional experiments, strict separation of tissue and soluble forms, harmonised preanalytics, prospective multicentre validation and demonstration of incremental value beyond symptoms and expert imaging.

Frontiers in Molecular BiosciencesVol. 13
Medical University of Warsaw (PL), Uniwersytet Kaliski im. Prezydenta Stanisława Wojciechowskiego (PL), National Medical Institute of the Ministry of Interior and Administration (PL)
European Commission
Good health and well-being
Endometriosis Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon